DELRAY BEACH, Fla. — PositiveID Corporation(OTCQB:PSID), a life sciences company focused on detection and diagnostics, today announced that its subsidiary, ExcitePCR Corporation, has hired David L. Politis as its Chief Marketing & Sales Officer. In his role as CMSO, Politis will direct and implement all marketing, sales and business development efforts for ExcitePCR as it prepares […]
Independent new company will accelerate development of Illumina’s forensic genomics technologies to enable more insight than traditional methods SAN DIEGO —- Illumina, Inc. (NASDAQ: ILMN) today announced plans with Telegraph Hill Partners (THP), a San Francisco-based venture capital and growth equity firm, to establish Verogen, Inc. The independent new company has certain exclusive rights to provide Illumina’s forensic sequencing technology to forensic customers, […]
DNAnexus has teamed up with Saphetor, a leading variant analysis company, to build a sample-in, report-out genomic analysis solution. Saphetor annotates and classifies genetic variants from next-generation sequencing (NGS) data to help clinicians quickly and accurately diagnose disease to make faster, more precise treatment decisions. Saphetor’s technology is now available on the DNAnexus cloud-based platform. Saphetor has […]
Seattle, WA – RareCyte, Inc., a global rare cell detection and liquid biopsy company will use the funding to advance its commercial sales efforts and build companion diagnostics (CDx) programs with strategic partners. The Company will also expand its regulatory infrastructure and research and development efforts. The $30M investment was led by 5AM Ventures with participation from […]
Obtain DNA or RNA Extraction in Three Minutes with New Arcis Prep Kit from Cole-Parmer August 23, 2017, Vernon Hills, Illinois – The Arcis Prep Kit, from Cole-Parmer, allows rapid extraction of either DNA or RNA in three minutes with high yields. This process is ideal for any molecular biologist who wants to reduce […]
Notable private equity firm invests £2.5 million in the Cambridge-based biotech Private equity firm Calculus Capital, a leading EIS and VCT investor, has further expanded its life science portfolio, by investing £2.5m in Cambridge-based Axol Bioscience (Axol), a provider of stem cells produced from reprogrammed human blood and tissue cells. Axol supplies the world’s top […]
– Leading innovator in drug development brings more than three decades of biotechnology and pharmaceutical experience to the company’s Board of Directors – PLEASANTON, Calif. – 10x Genomics, a company focused on enabling the mastery of biology by accelerating genomic discovery, today announced that Mathai Mammen, M.D., Ph.D. has been appointed to the company’s Board […]
SGI-DNA’s benchtop automated DNA printer to accelerate genomic research as part of VIB’s Technology Watch Initiative SGI-DNA Inc., a Synthetic Genomics Inc. (SGI) company, and VIB, a Belgian life science research institute, today announced that VIB will become the first institute in Europe to integrate the BioXp™ 3200 System in its workflows as part of […]
Company Partners with Leading Chinese Bio Security Firm to Bring Its Proprietary CANARY Technology to China Baltimore, Maryland Baltimore biotech firm, PathSensors, Inc., announced today it has partnered with a leading Chinese bio security firm, to bring its proprietary CANARY pathogen detection technology and high throughput testing solutions to the Chinese market. As part of […]
PLEASANTON, Calif. — Unchained Labs, the life sciences company that’s all about getting biologics researchers the right tool for the job, launched Lunatic today at the Bioprocessing Summit conference in Boston. Lunatic, a.k.a. The Concentration Liberator, makes batch quantification of protein, DNA and RNA a reality for biologics and genomics researchers. Lunatic is the only UV/Vis system out […]
Pay Invoice
Latest Blogs
-
Laboratory Tool Companies’ Dividends Show Stability
September 29, 2026 10:14 am
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.

